DK17885D0 - Antiviralt middel - Google Patents

Antiviralt middel

Info

Publication number
DK17885D0
DK17885D0 DK17885A DK17885A DK17885D0 DK 17885 D0 DK17885 D0 DK 17885D0 DK 17885 A DK17885 A DK 17885A DK 17885 A DK17885 A DK 17885A DK 17885 D0 DK17885 D0 DK 17885D0
Authority
DK
Denmark
Prior art keywords
antiviral agent
antiviral
agent
Prior art date
Application number
DK17885A
Other languages
English (en)
Inventor
Karl-Anders Karlsson
Erling Norrby
Goeran Wadell
Original Assignee
Karlsson Karl Anders
Erling Norrby
Goeran Wadell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karlsson Karl Anders, Erling Norrby, Goeran Wadell filed Critical Karlsson Karl Anders
Priority to DK17885A priority Critical patent/DK17885D0/da
Publication of DK17885D0 publication Critical patent/DK17885D0/da
Priority to IE7586A priority patent/IE59036B1/en
Priority to DE8686900753T priority patent/DE3680037D1/de
Priority to PCT/DK1986/000007 priority patent/WO1986003971A1/en
Priority to EP19860900753 priority patent/EP0207984B1/en
Priority to AT86900753T priority patent/ATE64853T1/de
Priority to US06/916,542 priority patent/US4859769A/en
Priority to AU53513/86A priority patent/AU580136B2/en
Priority to JP61500832A priority patent/JPS62502260A/ja
Priority to CN86100608A priority patent/CN86100608A/zh
Priority to IL7760386A priority patent/IL77603A/en
Priority to FI863702A priority patent/FI93227C/fi
Priority to NO863646A priority patent/NO173298C/no
Priority to DK439186A priority patent/DK439186D0/da
Priority to US07/368,188 priority patent/US4980462A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18851—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DK17885A 1985-01-14 1985-01-14 Antiviralt middel DK17885D0 (da)

Priority Applications (15)

Application Number Priority Date Filing Date Title
DK17885A DK17885D0 (da) 1985-01-14 1985-01-14 Antiviralt middel
IE7586A IE59036B1 (en) 1985-01-14 1986-01-10 Antiviral agents
JP61500832A JPS62502260A (ja) 1985-01-14 1986-01-13 抗ウイルス剤
US06/916,542 US4859769A (en) 1985-01-14 1986-01-13 Antiviral agents
PCT/DK1986/000007 WO1986003971A1 (en) 1985-01-14 1986-01-13 Antiviral agents
EP19860900753 EP0207984B1 (en) 1985-01-14 1986-01-13 Antiviral agents
AT86900753T ATE64853T1 (de) 1985-01-14 1986-01-13 Antivirale mittel.
DE8686900753T DE3680037D1 (de) 1985-01-14 1986-01-13 Antivirale mittel.
AU53513/86A AU580136B2 (en) 1985-01-14 1986-01-13 A second-step virus binding receptor
CN86100608A CN86100608A (zh) 1985-01-14 1986-01-14 制备抗病毒剂的方法
IL7760386A IL77603A (en) 1985-01-14 1986-01-14 Pharmaceutical compositions comprising saccharides having antiviral activity and a new 2-(substituted hydrocarbylsulfonyl) ethylsaccharide
FI863702A FI93227C (fi) 1985-01-14 1986-09-12 Hiilihydraattiyhdisteen käyttö in vitro viruspartikkelien tai viruksen pintakomponenttien valmistukseen tai eristämiseen
NO863646A NO173298C (no) 1985-01-14 1986-09-12 Anvendelse av karbohydratforbindelse med virusbindende egenskaper for in vitro diagnose av virusinfeksjoner eller for fremstilling eller isolering av viruspartikler eller virusoverflatekomponenter
DK439186A DK439186D0 (da) 1985-01-14 1986-09-12 Antivirale midler
US07/368,188 US4980462A (en) 1985-01-14 1989-06-19 Antiviral agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK17885A DK17885D0 (da) 1985-01-14 1985-01-14 Antiviralt middel

Publications (1)

Publication Number Publication Date
DK17885D0 true DK17885D0 (da) 1985-01-14

Family

ID=8090653

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17885A DK17885D0 (da) 1985-01-14 1985-01-14 Antiviralt middel

Country Status (11)

Country Link
US (2) US4859769A (da)
EP (1) EP0207984B1 (da)
JP (1) JPS62502260A (da)
CN (1) CN86100608A (da)
AU (1) AU580136B2 (da)
DK (1) DK17885D0 (da)
FI (1) FI93227C (da)
IE (1) IE59036B1 (da)
IL (1) IL77603A (da)
NO (1) NO173298C (da)
WO (1) WO1986003971A1 (da)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3819870A1 (de) * 1987-06-12 1988-12-29 Hoerrmann Wilhelm Arzneimittel auf der basis von fett-amino-alkoholen
US5534553A (en) * 1987-06-12 1996-07-09 Hoerrmann; Wilhelm Drug containing fatty amino alcohols or derivatives thereof
US5079353A (en) * 1987-12-02 1992-01-07 Chembiomed, Ltd. Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation
US5344870A (en) * 1987-12-02 1994-09-06 Alberta Research Council Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation
WO1989008499A1 (fr) * 1988-03-17 1989-09-21 Nippon Fine Chemical Co., Ltd. Liposome
IT1235011B (it) * 1988-07-26 1992-06-16 Fidia Farmaceutici Sintesi di derivati di glicosfingolipidi ed in particolare di gangliosidi utilizzabili per la preparazione di immunoadsorbenti ed adsorbenti per affinita' impiegabili per la purificazione di anticorpi e di tossine specifiche, e per uso diagnostico
US5149782A (en) * 1988-08-19 1992-09-22 Tanox Biosystems, Inc. Molecular conjugates containing cell membrane-blending agents
DE3840044A1 (de) * 1988-11-27 1990-06-07 Behringwerke Ag Glykosphingolipide mit kopplungsfaehiger gruppe im sphingoidanteil, ihre herstellung und verwendung
US6407072B1 (en) * 1988-12-02 2002-06-18 Fidia S.P.A. Lysoganglioside derivatives
IT1235161B (it) * 1988-12-02 1992-06-22 Fidia Farmaceutici Derivati di lisogangliosidi
US5192551A (en) * 1989-05-02 1993-03-09 Johns Hopkins University Neutral glycolipid as an adsorbent for enteric viral pathogens
WO1991008748A1 (en) * 1989-12-13 1991-06-27 Glycomed Incorporated Synthesis of rotavirus receptor saccharides
WO1991008747A1 (en) * 1989-12-13 1991-06-27 Glycomed Incorporated Synthetic receptor molecules recognizable by a rotavirus
US5466681A (en) * 1990-02-23 1995-11-14 Microcarb, Inc. Receptor conjugates for targeting penicillin antibiotics to bacteria
US6391857B1 (en) 1990-06-18 2002-05-21 Stanford University Methods and compositions for endothelial binding
US6387884B1 (en) 1990-06-18 2002-05-14 Stanford University Leukocyte homing modulation
JP2911554B2 (ja) * 1990-06-25 1999-06-23 台糖株式会社 抗ウィルス剤
EP0491960B1 (en) * 1990-06-27 1996-03-20 Dainippon Ink And Chemicals, Inc. Alkylated oligosaccharide and acetyl derivative thereof
DK0553113T3 (da) * 1990-08-02 1999-08-09 Antex Biolog Inc Adhæsionsreceptorer for patogene eller opportunistiske mikroorganismer
DK0563256T3 (da) * 1990-12-21 1995-08-28 Microcarb Inc Anvendelse af værtscelle-phospholipider til inhibering af bakteriekolonisering
US5843463A (en) * 1990-12-21 1998-12-01 Antexbiologics, Inc. Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae
US6121233A (en) * 1991-04-19 2000-09-19 John L. Magnani Methods for the inhibition of cancer metastasis mediated by endothelial adhesion molecules
US5936076A (en) * 1991-08-29 1999-08-10 Kirin Beer Kabushiki Kaisha αgalactosylceramide derivatives
JPH05279381A (ja) * 1991-09-13 1993-10-26 Dainippon Ink & Chem Inc 硫酸化オリゴ糖芳香族配糖体
GB9219562D0 (en) 1992-03-11 1992-10-28 Prendergast Kennet F Anti-viral peptides
TW261533B (da) * 1992-07-16 1995-11-01 Kirin Brewery
AU683026B2 (en) * 1992-10-22 1997-10-30 Kirin Pharma Kabushiki Kaisha Novel shingoglycolipid and use thereof
CA2153661A1 (en) * 1993-01-12 1994-07-21 Anthony George Gristina Methods and compositions for the direct concentrated delivery of passive immunity
CA2160566C (en) * 1993-04-15 2004-07-13 Tatsuo Higa Novel sphingoglycolipids and uses thereof
CA2171614C (en) * 1994-07-15 2008-04-15 Mamoru Koketsu Pharmaceutical composition containing sialic acid derivatives
EP0959352A1 (en) * 1994-07-27 1999-11-24 The Dow Chemical Company Determining biodegradability of aspartic acid derivatives, degradable chelants, uses and compositions thereof
US5606512A (en) * 1994-07-27 1997-02-25 The Dow Chemical Company Determining the biodegradability of iminodiacetic acid derivatives
US5730157A (en) * 1995-12-07 1998-03-24 Clarion Pharmaceuticals Inc. Method for treating viral infection
US5973128A (en) * 1996-11-22 1999-10-26 The Hospital For Sick Children Research And Development Lp Glycolipid mimics and methods of use thereof
US6083921A (en) * 1998-01-12 2000-07-04 Xu; Kai Jian Pharmaceutical compositions and method of using same
KR100601330B1 (ko) * 1999-02-23 2006-07-14 다카라 바이오 가부시키가이샤 황산화 푸코갈락탄
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof
US7135173B2 (en) * 2000-07-13 2006-11-14 Idaho Research Foundation, Inc. Antiviral activity of Shiga toxin
US6541013B1 (en) 2000-07-13 2003-04-01 Idaho Research Foundation, Inc. Methods and compositions for suppressing bovine leukemia virus with a Shiga toxin polypeptide
JP2005504017A (ja) * 2001-06-29 2005-02-10 バイオティ セラピィーズ コープ 少なくとも１種の糖含有阻害性物質の用途
FI20011403A7 (fi) * 2001-06-29 2002-12-30 Carbion Oy Menetelmä ja koostumukset vatsan sairauksien hoitoon
AU2002364288A1 (en) * 2001-12-28 2003-07-15 Pirelli & C. S.P.A. Water-resistant telecommunication cable
JP5183010B2 (ja) 2002-05-16 2013-04-17 グリコミメティクス， インコーポレイテッド セレクチンによって媒介される機能を阻害するための化合物および方法
EP1539251A4 (en) * 2002-07-03 2009-02-25 Glycomimetics Inc COMPOSITIONS AND METHODS FOR DIAGNOSIS AND THERAPY OF MEDICAL DISEASES WITH ANGIOGENESIS
CN1705488A (zh) * 2002-10-22 2005-12-07 独立行政法人科学技术振兴机构 登革热病毒感染抑制剂
BR0316402A (pt) * 2002-11-21 2006-02-21 Pevion Biotech Ltd vesìcula fusogênica, métodos para preparar uma vesìcula fusogênica encapsulante, e para encapsular pelo menos uma substáncia terapêutica ou imunologicamente ativa em uma vesìcula fusogênica, uso de uma vesìcula fusogênica, e, formulação farmacêutica
US20040219158A1 (en) * 2003-05-02 2004-11-04 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria
JP2007524658A (ja) * 2003-11-19 2007-08-30 グリコミメティクス， インコーポレイテッド Ｅ−およびｐ−セレクチンの両方のための糖模倣物アンタゴニスト
ATE383367T1 (de) * 2003-11-19 2008-01-15 Glycomimetics Inc Spezifischer antagonist sowohl für e- als auch p- selektine
US8137397B2 (en) * 2004-02-26 2012-03-20 Boston Scientific Scimed, Inc. Medical devices
US8201377B2 (en) * 2004-11-05 2012-06-19 Faus Group, Inc. Flooring system having multiple alignment points
WO2006127906A1 (en) * 2005-05-25 2006-11-30 Glycomimetics, Inc. Heterobifunctional compounds for selectin inhibition
ES2375979T3 (es) * 2005-08-09 2012-03-07 Glycomimetics, Inc. Inhibidores glicomiméticos de la lectina pa-il, lectina pa-iil o ambas lectinas de pseudomonas.
DK2264043T3 (da) 2005-09-02 2018-01-29 Glycomimetics Inc Heterobifunktionelle pan-selektin-inhibitorer
WO2007143052A1 (en) * 2006-06-01 2007-12-13 Glycomimetics, Inc. Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas
CA2666103C (en) * 2006-10-12 2014-02-18 Glycomimetics, Inc. Glycomimetic replacements for hexoses and n-acetyl hexosamines
CA2677747A1 (en) * 2007-02-09 2008-08-21 Glycomimetics, Inc. Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
US8039442B2 (en) 2007-07-18 2011-10-18 Glycomimetics, Inc. Compounds and methods for treatment of sickle cell disease or complications associated therewith
WO2009126556A1 (en) 2008-04-08 2009-10-15 Glycomimetics, Inc. Pan-selectin inhibitor with enhanced pharmacokinetic activity
CN102088983B (zh) * 2008-06-13 2013-01-30 糖模拟物有限公司 利用选择的糖模拟化合物的血液癌症的治疗
JP5726171B2 (ja) * 2009-05-01 2015-05-27 グリコミメティックス インコーポレイテッド Ｅ−セレクチンおよびｃｘｃｒ４ケモカイン受容体のヘテロ二官能性阻害剤
US8921328B2 (en) 2010-09-14 2014-12-30 Glycomimetics, Inc. E-selectin antagonists
US9109002B2 (en) 2011-12-22 2015-08-18 Glycomimetics, Inc. E-selectin antagonist compounds, compositions, and methods of use
LT2928476T (lt) 2012-12-07 2018-05-25 Glycomimetics, Inc. Junginiai, kompozicijos ir būdai, naudojant e-selektino antagonistus, hemopoetinių ląstelių mobilizacijai
PL3227310T3 (pl) 2014-12-03 2020-02-28 Glycomimetics, Inc. Heterodwufunkcyjne inhibitory selektyn E i receptorów chemokinowych CXCR4”
CA3009836A1 (en) 2016-01-22 2017-07-27 Glycomimetics, Inc. Glycomimetic inhibitors of pa-il and pa-iil lectins
WO2017151708A1 (en) 2016-03-02 2017-09-08 Glycomimetics, Inc. Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin
JP2019524791A (ja) 2016-08-08 2019-09-05 グリコミメティクス， インコーポレイテッド Ｅ−セレクチンの阻害剤もしくはｃｘｃｒ４の阻害剤との、またはｅ−セレクチンおよびｃｘｃｒ４両方のヘテロ二機能性阻害剤とのｔ細胞チェックポイント阻害剤の組み合わせ
CN109890421B (zh) 2016-10-07 2023-10-20 糖模拟物有限公司 高效的多聚体e-选择蛋白拮抗剂
US11197877B2 (en) 2017-03-15 2021-12-14 Glycomimetics. Inc. Galactopyranosyl-cyclohexyl derivauves as E-selectin antagonists
US11712446B2 (en) 2017-11-30 2023-08-01 Glycomimetics, Inc. Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
EP3732186A1 (en) 2017-12-29 2020-11-04 GlycoMimetics, Inc. Heterobifunctional inhibitors of e-selectin and galectin-3
KR20200128025A (ko) 2018-03-05 2020-11-11 글리코미메틱스, 인크. 급성 골수성 백혈병 및 관련 병태의 치료 방법
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3
CN114920788B (zh) * 2022-05-30 2024-07-30 天津科技大学 人乳三糖半乳糖基乳糖的制备

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3622666A (en) * 1968-03-04 1971-11-23 Stanley Drug Products Inc Methods for treating bacterial infections with phrenosin
DE1910715A1 (de) * 1968-03-04 1969-10-09 Stanley Drug Products Inc Antimikrobielle Faktoren und deren Verwendung
DE2322562C2 (de) * 1972-11-06 1984-03-29 Pharmacia AB, Uppsala Verfahren zur Bestimmung von Antigenen in einer Probe
US4056322A (en) * 1973-12-14 1977-11-01 Strategic Medical Research Corporation Preparation of ethers of monosaccharides
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
FR2478104B1 (fr) * 1980-03-17 1986-08-08 Merieux Inst Nouveaux derives de gangliosides, leur preparation et leur application
US4397959A (en) * 1980-11-05 1983-08-09 Research Corporation Forced precipitation method for preparing antigen/antibody particles
US4476119A (en) * 1981-08-04 1984-10-09 Fidia S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
US4678747A (en) * 1983-02-18 1987-07-07 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies for detection of an H (O) blood group antigen
SE8304007D0 (sv) * 1983-07-15 1983-07-15 Karlsson Karl Anders Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
IT1168205B (it) * 1983-07-21 1987-05-20 Wellcome Italia Derivato di monsialo ganglioside dotato di attivita' antibatterica, antifungina ed antitumorale, composizioni che lo contengono e procedimento per la loro preparazione
EP0146810A3 (de) * 1983-12-05 1987-05-13 Solco Basel AG Verfahren zur Herstellung von Sphingosinderivaten
US4695553A (en) * 1985-11-01 1987-09-22 Becton Dickinson And Co., Inc. Method for increasing agglutination of groups of cells to produce improved cell layer interface in centrifuged blood sample using antibodies

Also Published As

Publication number Publication date
FI93227B (fi) 1994-11-30
AU580136B2 (en) 1989-01-05
EP0207984A1 (en) 1987-01-14
WO1986003971A1 (en) 1986-07-17
US4980462A (en) 1990-12-25
IE59036B1 (en) 1993-12-15
EP0207984B1 (en) 1991-07-03
CN86100608A (zh) 1987-02-18
NO173298B (no) 1993-08-16
FI93227C (fi) 1995-03-10
IL77603A (en) 1994-12-29
NO863646L (no) 1986-11-14
NO863646D0 (no) 1986-09-12
NO173298C (no) 1993-11-24
AU5351386A (en) 1986-07-29
IE860075L (en) 1986-07-14
JPS62502260A (ja) 1987-09-03
FI863702L (fi) 1986-09-12
FI863702A0 (fi) 1986-09-12
US4859769A (en) 1989-08-22

Similar Documents

Publication Publication Date Title
DK17885D0 (da) Antiviralt middel
FI861069L (fi) Antivirala nukleosider.
FI861822A7 (fi) Antivirala kompositioner.
NO863014L (no) Antiparasittisk middel.
DK603386D0 (da) Plantemikrobicidt middel
LU90099I2 (fr) Fluodioxonil (celest)
DK437885A (da) Luftfriskende middel
DK500585D0 (da) Immunoregulerende middel
DK390986D0 (da) Guaninderivater
NO863536L (no) Fuktighetsbevarende middel.
ATA155686A (de) Giesspfannenkopf
DK646487D0 (da) Froedesinficerende middel
DK24285A (da) Fungicidt middel
DK485088A (da) Antiviralt middel
AT386920B (de) Maishaecksler
ATA122686A (de) Kettenschloss
ATA367885A (de) Rollstuhl
DK598185D0 (da) Vandbloedgoerende middel
DK439186D0 (da) Antivirale midler
DK363985D0 (da) Antineoplastisk middel
MX9203102A (es) Agentes antivirales de tiadiazol.
KR860010473U (ko) 인명 구조용 바스켙
DK362687D0 (da) Desensibiliserende dentalt middel
RO93177A2 (ro) Solutie cicatrizanta
ES289953Y (es) Conjunto de supervivencia

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment